Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "work type" (1) AND "fulltext" .

Search without a query returns a maximum of 500 hits!

201 - 210 / 500
First pagePrevious page17181920212223242526Next pageLast page
201.
Dry-sliding wear resistance of AISI H11-type hot-work tool steel
Gašper Puš, Borut Žužek, Agnieszka Guštin, Bojan Podgornik, 2023, original scientific article

Keywords: hot-work tool steel, friction, sliding wear, mechanical properties
Published in DiRROS: 08.03.2024; Views: 63; Downloads: 37
.pdf Full text (2,04 MB)
This document has many files! More...

202.
Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma
Janja Ocvirk, Marko Boc, Martina Reberšek, Tanja Roš-Opaškar, 2009, original scientific article

Abstract: Background. Cisplatin, a widely used antineoplastic agent usually induces peripheral neuropathy, but can rarely also complicate with encephalopathy, with or without seizures. Case report. We report a case of a young patient with metastatic malignant melanoma with signs and symptoms of cisplatin-induced non-convulsive posterior reversible encephalopaty syndrome. Within the days shortly after the first cycle of cisplatin based chemotherapy the patient suffered from nausea, vomitus, headache, severe pain at the site of sub-cutaneous metastases and confusion. She later experienced somnolence, cortical blindness and aphasia, but without epileptic seizures. Conclusions. Cisplatin is an effective chemotherapeutic drug but also very toxic one and physicians using it must also be aware of possible encephalopathy.
Published in DiRROS: 08.03.2024; Views: 58; Downloads: 24
.pdf Full text (343,74 KB)

203.
Advances in the treatment of metastatic colorectal carcinoma
Janja Ocvirk, 2009, review article

Published in DiRROS: 08.03.2024; Views: 50; Downloads: 28
.pdf Full text (89,98 KB)

204.
Influence of magnesium sulphate infusion before total thyroidectomy on transient hypocalcemia - a randomised study
Nikola Bešić, Špela Žagar, Gašper Pilko, Barbara Perić, Marko Hočevar, 2008, original scientific article

Abstract: Background. Transient hypocalcemia is the most common complication after thyroidectomy. Normomagnesemia is needed for normal secretion of PTH and end-organ responsiveness. Our aim was to determine the influence of infusion of magnesium sulphate before thyroidectomy on the incidence of laboratory and clinical transient hypocalcemia. Methods. In our prospective study, 48 patients (5 men, 43 women; age 22-73 years, median 45 years), who underwent total or near-total thyroidectomy, were randomised preoperatively. Half of them received intravenously 4 ml of 1M magnesium sulphate at the beginning of the surgical procedure, the other half were the control group. Serum concentrations of calcium, ionised calcium, magnesium, phosphate, albumin and PTH were measured prior to surgery and on the first day after surgery. Results. Laboratory postoperative hypocalcemia was present in 27% of patients and 23% of patients had clinical signs and/or symptoms of postoperative hypocalcemia. The concentration of total calcium (p=0.024) and of albumin (p=0.01) was lower in the group that received magnesium sulphate. Conclusions.The patients who received infusion of magnesium sulphate before total thyroidectomy had lower concentration of total serum calcium and albuminin comparison to the control group. There was no statistical differencein the incidence of clinical transient hypocalcemia.
Published in DiRROS: 08.03.2024; Views: 55; Downloads: 20
.pdf Full text (72,12 KB)

205.
Extensive squamous cell carcinoma of the lower lid
Boris Jančar, 2008, professional article

Published in DiRROS: 08.03.2024; Views: 65; Downloads: 20
.pdf Full text (99,83 KB)

206.
In search of the shortest regimen: fractionation of a fully isoeffective combination of hyperfractionated and hypofractionated treatment
Andrej Strojnik, 2008, professional article

Abstract: Purpose. To analyze the possibility of reducing the number of fractions but maintaining the full biological effect of radiotherapy by varying the dose perfraction. Methods. An arbitrary treatment with a constant dose per fractionis substituted for a fully isoeffective combination of a hyperfractionated and hypofractionated treatment. The number of fractions of the combined treatment is derived. All calculations are based on the linear-quadratic model. Conclusions. Standard uniform fractionation requires the fewest fractions. Any variation in dose per fraction increases the number of fractions of a fully isoeffective treatment.
Published in DiRROS: 08.03.2024; Views: 60; Downloads: 15
.pdf Full text (66,71 KB)

207.
Optimization of electrode position and electric pulse amplitude in electrochemotherapy
Anže Županič, Selma Čorović, Damijan Miklavčič, 2008, original scientific article

Abstract: Background. In addition to the chemotherapeutic drug being present within the tumor during electric pulse delivery, successful electrochemotherapy requires the entire tumor volume to be subjected to a sufficiently high electric field,while the electric field in the surrounding healthy tissue is as low as possible to prevent damage. Both can be achieved with appropriate positioning of the electrodes and appropriate amplitude of electric pulses. Methods. We used 3D finite element numerical models and a genetic optimization algorithm to determine the optimum electrode configuration and optimum amplitude of electric pulses for treatment of three subcutaneous tumor models of different shapes and sizes and a realistic brain tumor model acquired from medical images. Results. In all four tumor cases, parallel needle electrode arrays were a better choice than hexagonal needle electrode arrays, since their utilization required less electric current and caused less healthy tissue damage. In addition, regardless of tumor geometry or needle electrode configuration, the optimum depth of electrode insertion was in all cases deeper than the deepest part of the tumor. Conclusions. Our optimization algorithm was able to determine the best electrode configuration in all four presented models and with further improvement it could be a useful tool in clinical electrochemotherapy treatment planning.
Published in DiRROS: 08.03.2024; Views: 68; Downloads: 22
.pdf Full text (248,14 KB)

208.
209.
Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells
Suzana Vidic, Urška Kamenšek, Maja Čemažar, 2008, original scientific article

Abstract: Background. Silencing oncogenes or other genes that contribute to tumor malignancy and progression offers a promising approach to treating cancer. Specific and efficient silencing of gene expression can be achieved by RNA interference (RNAi) technology using small interfering RNA (siRNA) or short hairpin RNA (shRNA). However, a major challenge in RNAi technology is effective delivery of interfering molecules into target cells. The aim of our study was to evaluate electroporation as a perspective method for efficient invitro transfection of LPB fibrosarcoma cells with plasmid DNA expressing shRNA. Methods. Induction of shRNA-mediated gene silencing by electroporation was determined by fluorescence microscopy, flow cytometry and western blot analysis. The effect of electroporation conditions on cell survival and proliferation was determined by clonogenic assay. Results and conclusions. Ourresults demonstrated that electroporation is a feasible and effective method for delivery of plasmid DNA expressing shRNA into cancer cells in vitro. Electrotransfection of murine LPB fibrosarcoma cells, continuously expressing green fluorescence protein - GFP (LPBGFP), with plasmid DNA encoding shRNA-GFP, reduced GFP expression, which was determined on the protein level, as well as by measurement of GFP fluorescence intensity. A pronounced reduction in GFP expression level was detected from the second to the fifth day after treatment. Moreover, the method is easy to perform and showed low cell damaging effects, which are the most important and preferential factors for further in vivo studies.
Published in DiRROS: 08.03.2024; Views: 58; Downloads: 20
.pdf Full text (391,23 KB)

210.
Cysteine cathepsins and stefins in head and neck cancer : an update of clinical studies
Primož Strojan, 2008, review article

Abstract: Background. Cancer of the head and neck represents a diverse group of malignant diseases; so far, no factor in a wide spectrum of biochemical and histological candidate-markers has yet been identified to predict reliably thenatural course of the disease or its response to the therapy to be used in routine clinical practice. Among the factors that promote tumor growth and invasion, several protease systems, implemented in proteolytic degradation of extracellular matrix components, were studied, including papain-like lysosomalcysteine proteases (e.g. cathepsins B and L) and their physiological inhibitors cystatins (e.g. stefins A and B, cystatin C). The aim of the present report is to review the published studies on clinical applicability ofcysteine cathepsins and their endogenous inhibitors stefins in squamous cellcarcinoma of the head and neck and to present recent research results fromthis area conducted jointly by the Institute of Oncology Ljubljana and ENTDepartment of the University Medical Center Ljubljana, Slovenia. Conclusions. According to our experience, immunohistochemical staining of cysteine cathepsins and stefins seems to be of limited value for predicting either treatment response or patientsć survival. However, the results of studies on stefin A in tumor tissue cytosols should be considered hypothesis-generating and deserves further evaluation in the frame of prospective controlled multicentric clinical study.
Published in DiRROS: 08.03.2024; Views: 52; Downloads: 21
.pdf Full text (988,33 KB)

Search done in 1.02 sec.
Back to top